STAG3 inhibitors belong to a class of chemical compounds that have gained attention in the field of molecular biology and chromosome segregation research. These inhibitors are specifically designed to target and modulate the activity of STAG3, which stands for Stromal Antigen 3. STAG3 is a protein that plays a critical role in the formation and maintenance of the cohesin complex, a multiprotein assembly involved in chromosome organization and segregation during cell division. The cohesin complex tethers sister chromatids together until they are ready to be separated during the cell cycle, ensuring the accurate distribution of genetic material to daughter cells.
STAG3 inhibitors exert their effects by interfering with the function or expression of STAG3, disrupting its role in the assembly and stability of the cohesin complex. This interference can lead to aberrations in chromosome segregation, resulting in aneuploidy or other genomic instability issues. Researchers employ STAG3 inhibitors as valuable tools to investigate the specific roles of STAG3 in various cellular contexts and to gain insights into the molecular mechanisms governing chromosome dynamics during cell division. While the precise applications and broader implications of STAG3 inhibitors are subjects of ongoing research, their utility in elucidating the complexities of chromosome segregation and genome stability is of paramount importance in advancing our understanding of cell biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase, potentially reducing STAG3 transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis, which could decrease overall protein levels, including STAG3. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibits DNA topoisomerase I, potentially leading to DNA damage and altered gene expression, including STAG3. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Crosslinks DNA, which could disrupt transcription and potentially decrease STAG3 expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
Inhibits DNA polymerase, potentially affecting DNA replication and STAG3 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Binds to DNA and alters transcription, which could affect STAG3 gene expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Targets DNA topoisomerase II, potentially affecting transcription and reducing STAG3 expression. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
Inhibits cyclin-dependent kinases, which may alter cell cycle progression and STAG3 transcription. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
A cyclin-dependent kinase inhibitor, potentially affecting transcription factors regulating STAG3 expression. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $75.00 $175.00 | 18 | |
Inhibits HMG-CoA reductase, potentially leading to downstream effects on STAG3 expression. | ||||||